AMERISAFE (AMSF) Q2 2024 earnings summary

Executive summary

• Net income for Q2 2024 was $11 million ($0.57 per diluted share), down from $15.6 million ($0.81 per share) in Q2 2023, with six-month net income at $27.9 million, down from $33 million year-over-year.

• Gross premiums written grew 6.6% year-over-year to $76.4 million, driven by policy count growth, strong retention, and increased audit premiums.

• Net premiums earned rose 4.6% to $68.6 million for Q2 2024.

• Underwriting profit declined 31.2% to $6.5 million, impacted by higher loss and loss adjustment expenses.

• Focus on small to mid-sized businesses in hazardous industries and proactive claims handling supported shareholder returns.

Financial highlights

• Total revenues for Q2 2024 were $75.8 million, nearly flat year-over-year; six-month revenues were $156.3 million, up 1.4%.

• Net investment income decreased 3.6% to $7.4 million year-over-year, but pre-tax investment yield rose to 3.3%.

• Net combined ratio increased to 90.5% from 85.4% in Q2 2023, driven by a higher net loss ratio of 59.2%.

• Book value per share was $15.78 at June 30, 2024.

• Return on average equity for Q2 2024 was 14.6%, down from 18.6% in Q2 2023.

Outlook and guidance

• Management expects continued pressure from medical inflation, but fee schedules are generally containing costs.

• The company maintained its initial estimate for the 2024 accident year loss and LAE ratio at 71.0% of net premiums earned.

• Wage inflation remains a positive factor for premium growth, though it is starting to wane.

• No changes to reserve assumptions are planned despite recent favorable development.

• Forward-looking statements caution that actual results may differ due to risks, uncertainties, and market factors.